Skip to main content
SpringerLink
Log in

Challenges and Emerging Issues in Patenting Nanomedicines

  • Chapter
  • First Online:
Patenting Nanomedicines

Abstract

Nanomedicine is the science and technology used for diagnosing, treating and preventing diseases, improving human health. The position of nanomedicine as on today is only a milestone on the road to introducing truly innovative technologies. A radical technological revolution in medicine is unfolding as a result of the fact that nanotechnology is no more confined to a part of the world and has become a global agenda. Site-specific targeted drug delivery and personalized medicine are areas where nanomedicine has already producing significant results. Although nanomedicine is a newly emerging interdisciplinary field, there are few nanomedicine products on the market, as well as several challenges to be overcome for commercialization that include technical, legal, environmental, safety, ethical and regulatory questions and merging thickets of overlapping patent claims. Thus, commercial nanomedicine is at a nascent stage of development and the full potential of nanomedicine is yet to be exploited.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

ANDA:

Abbreviated new drug application

CNS:

Central nervous system

CNT:

Carbon nanotube

EMEA:

Europe, the Middle East and Africa

FDA:

Food and drug administration

IARC:

International agency for research on cancer

MWNT:

Multi-walled

NCE:

New chemical entities

NCI:

National Cancer Institute

NNI:

National Nanotechnology Initiative

NSF:

National Science Foundation

PTO:

US Patent and Trademark Office

ROS:

Reactive oxygen species

SWNT:

Single-walled

WTO:

World Trade Organization

References

  • Agreement on Trade-Related Aspects of Intellectual Property Rights (2011) Article 27.1

    Google Scholar 

  • Agreement on Trade-Related Aspects of Intellectual Property Rights (2011) Article 33

    Google Scholar 

  • Ajayan PM (1999) Nanotubes from carbon. Chem Rev 99(7):1787–1800

    Article  Google Scholar 

  • Baker S, Aston A (2005) The business of nanotech. Bus Week 14:65–71

    Google Scholar 

  • Bawa R (2004a) A comprehensive nanotechnology library in miniature: a review of the Springer Handbook of Nanotechnology. Nanotechnol Law Bus 1:341–343

    Google Scholar 

  • Bawa R (2004b) Nanotechnology patenting in the US. Nanotechnol Law Bus 1:31–50

    Google Scholar 

  • Bawa R (2004c) Nanotechnology patents and challenges. Patent Cafe. www.cafezine.com/index_article. Accessed February 2011

  • Bawa R (2004d) Nanotechnology patents and the US Patent Office. Small Times 4

    Google Scholar 

  • Bawa R (2004e) Patenting nanotechnology inventions: challenges and opportunities. In: Proceedings of the Hawaii International Conference on Sciences, Honolulu, Hawaii

    Google Scholar 

  • Bawa R (2005a) The impact of the US Patent Office on nanotechnology. http://www.rpitechnology.com/?action=static&page=Resources. Accessed July 2011

  • Bawa R (2005b) Will nanomedicine “patent land grab” thwart commercialization?”. Nanomedicine 1:346–350

    Article  Google Scholar 

  • Bawa R, Bawa SR (2005) Protecting new inventions in nanomedicine. In: Wagner CG (ed) Foresight, innovation, and strategy: towards a wiser future. World Future Society, Bethesda

    Google Scholar 

  • Bawa R, Maebius S, Iver C, Bawa SR (2005a) Biotechnology patents: challenges and opportunities. In: Bronzino JD (ed) The CRC biomedical engineering handbook. CRC Press, Boca Raton

    Google Scholar 

  • Bawa R, Bawa SR, Maebius SB, Flynn T, Wei C (2005b) Protecting new ideas and inventions in nanomedicine via patents. Nanomedicine 1(2):150–158

    Article  Google Scholar 

  • Bawa R, Bawa SR, Maebius S, Iver C (2006) Bionanotechnology patents: challenges and opportunities. In: Bronzino JD (ed) The biomedical engineering handbook. CRC Press, Boca Raton

    Google Scholar 

  • Bawa R (2007a) Patents and nanomedicine. Nanomedicine 2(3):351–374

    Article  Google Scholar 

  • Bawa R (2007b) The future of nanomedicine. In: Mack T (ed) Hopes and visions for the 21st century. World Future Society Press, Bethesda

    Google Scholar 

  • EPODOC (2009) Database, 1993–2003

    Google Scholar 

  • ETC (2005) Nanotech’s “second nature” patents: implications for the global south. ETC Group, Ottawa

    Google Scholar 

  • Forman D (2004) P storm clouds build on horizon. Small Times (May/Jun): 21–24

    Google Scholar 

  • Freedonia (2007) Nanotechnology in healthcare. The Freedonia Group, Cleveland

    Google Scholar 

  • Gordon E, Hall F (2005) Nanotechnology blooms, at last. Oncol Rep 13:1003–1007

    Google Scholar 

  • Huang Z, Chen H, Yip H, Ng G, Guo F, Chen ZK (2003) Longitudinal patent analysis for nanoscale science and engineering: country, institution and technology field. J Nanopart Res 5:333–341

    Article  Google Scholar 

  • Hunt WH (2004) Nanomaterials: nomenclature, novelty and necessity. J Mater 56(10):13–18, Oct

    Google Scholar 

  • Kristof R, Benito B (2006) Nanomedicine: think big! Informa, London

    Google Scholar 

  • Kubik T, Bogunia-Kubik K, Sugusaka M (2005) Nanotechnology on duty in medical applications. Curr Pharm Biotechnol 6:17–33

    Google Scholar 

  • Lux Research (2004a) Nanotechnology gold rush yields crowded, entangled patents. Lux Research, New York. http://www.prnewswire.com/news-releases/nanotechnology-gold-rush-yields-crowded-entangled-patents54373177.html. Accessed April 2011

  • Lux Research (2004) Sizing nanotechnology’s value chain. Lux Research, New York

    Google Scholar 

  • Miller JC, Serrato R, Represas-Cardenas JM, Kundahl G (2004) Handbook of nanotechnology business, policy and intellectual property law. Wiley, New York

    Google Scholar 

  • NanoMarket Report (2007) Nanotechnology now. http://www.nanotech-now.com/new. Accessed September 2011

  • Niemeyer CM, Mirkin CA (2004) Nanobiotechnology-concepts, applications and prospectives. Wiley-VCH Verlag Gmbh & Co, Weinhelm

    Book  Google Scholar 

  • Oas B (2006) Life cycle management. Tablet and Capsules Oct: 12–20

    Google Scholar 

  • Park C, Ounaies Z, Watson KA, Crooks RE, Smith J, Lowther SE, Connell JW, Siochi EJ, Harrison JS, Sta Clair TL (2002) Dispersion of single wall carbon nanotubes by in situ polymerization under sonication. Chem Phys Lett 364:303–308

    Article  Google Scholar 

  • Paull R, Wolfe J, Hebert P, Sinkula M (2003) Investing in nanotechnology. Nat Biotechnol 21:1144–1147

    Article  Google Scholar 

  • Regaled A (2004) Nanotechnology patents surge as companies vie to stake claim. Wall Street J Sect A:1

    Google Scholar 

  • Service R (2005) Nanotechnology takes aim at cancer. Science 310:1132–1134

    Article  Google Scholar 

  • Shapiro C (2000) Navigating the patent thicket: cross licenses, patent pools, and standard-setting. Innovation Policy Econ 1:119–150

    Google Scholar 

  • Thassu D, Deleers M, Pathak Y (2007) Latest technologies related to nanoparticles in drug delivery. Nanoparticulate drug del systems. Informa Healthcare, New York

    Google Scholar 

  • Vo-Dinh T (2007) Nanotechnology in biology and medicine- methods, devices and applications. CRC Press, Boca Raton

    Book  Google Scholar 

  • Wagner V, Dullaart A, Bock A, Zweck A (2006) The emerging nanomedicine landscape. Nat Biotechnol 24:1211–1217

    Article  Google Scholar 

  • World Intellectual Property Organization (2009) Patents: frequently asked questions. http://www.wipo.int/patentscope/en/patents_faq.html#protection. Accessed February 2011

Download references

Author information

Authors and Affiliations

  1. I.S.F. College of Pharmacy, Ferozepur Road, Ghal Kalan, Moga, 142001, Punjab, India

    Rayasa S. Ramachandra Murthy

Authors
  1. Rayasa S. Ramachandra Murthy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rayasa S. Ramachandra Murthy .

Editor information

Editors and Affiliations

  1. , Faculty of Health Sciences, University Fernando Pessoa, Rua Carlos da Maia 296, Cacif, Porto, 4200-150, Portugal

    Eliana B. Souto

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Murthy, R.S.R. (2012). Challenges and Emerging Issues in Patenting Nanomedicines. In: Souto, E. (eds) Patenting Nanomedicines. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-29265-1_2

Download citation

Publish with us

Policies and ethics

Search

Navigation